DIAGENS-B (02526) Company Profile - Company Info, Industry & Management

返回 Overview News Financials Shareholders Profile IPO ›

Industry

Medical Devices 0.46%

45 stocks in this industry

3 >7%

2 5~7%

1 3~5%

12 0~3%

8 0%

13 0~3%

4 3~5%

0 5~7%

2 >7%

Down 18 Up 19

Industry RankingsValue (HKD)Rank

Revenue (Last FY)192.81M31/44

Net Profit (Last FY)-78.73M33/44

ROE (Last FY)-40.51%45/49

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

Management

NamePosition

宋宁 Executive Director

翁资欣 Executive Director

徐晨 Non-Executive Director

邬玲仟 Non-Executive Director

杨泽浩 Non-Executive Director

查扬 Independent Non-Executive Director

张竞 Independent Non-Executive Director

王开峰 Independent Non-Executive Director

Board list from the HKEXnews "List of Directors and their Role and Function", as of 2026-03-27.

About this page

This page shows DIAGENS-B (02526) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.

DIAGENS-B 02526

Company Information

Industry

Management

DIAGENS-B 02526·

Company Information

Industry

Management

DIAGENS-B 02526